KR100470734B1 - Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof - Google Patents
Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof Download PDFInfo
- Publication number
- KR100470734B1 KR100470734B1 KR10-2002-0034215A KR20020034215A KR100470734B1 KR 100470734 B1 KR100470734 B1 KR 100470734B1 KR 20020034215 A KR20020034215 A KR 20020034215A KR 100470734 B1 KR100470734 B1 KR 100470734B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- ganoderma lucidum
- kctc
- mycelium
- supernatant
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
- G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
- G11B33/06—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon combined with other apparatus having a different main function
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60R—VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR
- B60R11/00—Arrangements for holding or mounting articles, not otherwise provided for
- B60R11/02—Arrangements for holding or mounting articles, not otherwise provided for for radio sets, television sets, telephones, or the like; Arrangement of controls thereof
- B60R11/0211—Arrangements for holding or mounting articles, not otherwise provided for for radio sets, television sets, telephones, or the like; Arrangement of controls thereof for record carriers apparatus, e.g. video recorders, tape players or CD players
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B31/00—Arrangements for the associated working of recording or reproducing apparatus with related apparatus
- G11B31/02—Arrangements for the associated working of recording or reproducing apparatus with related apparatus with automatic musical instruments
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
- G11B33/12—Disposition of constructional parts in the apparatus, e.g. of power supply, of modules
- G11B33/121—Disposition of constructional parts in the apparatus, e.g. of power supply, of modules the apparatus comprising a single recording/reproducing device
- G11B33/122—Arrangements for providing electrical connections, e.g. connectors, cables, switches
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60R—VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR
- B60R11/00—Arrangements for holding or mounting articles, not otherwise provided for
- B60R11/02—Arrangements for holding or mounting articles, not otherwise provided for for radio sets, television sets, telephones, or the like; Arrangement of controls thereof
- B60R2011/0276—Arrangements for holding or mounting articles, not otherwise provided for for radio sets, television sets, telephones, or the like; Arrangement of controls thereof for rear passenger use
Landscapes
- Engineering & Computer Science (AREA)
- Multimedia (AREA)
- Mechanical Engineering (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체 배양액으로부터 고분자 물질(Exo-polymer)을 생산하는 방법 및 그 용도에 관한 것으로 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체를 영지버섯 합성배지에 접종하고 pH 4∼7, 온도 25∼35℃에서 1vvm의 속도로 공기를 공급하면서 50∼150rpm으로 교반하여 10∼30일간 액체배양 다음 상기 배양액을 5,000∼15,000×g로 10∼30분간 원심분리한 후 상층액을 에탄올 처리하여 침전물을 획득하고 동결건조한 다음 증류수에 용해한 후 원심분리하고 투석함으로써 분리한 고분자 물질은 단백질 17.2% 및 탄수화물 82.8%로 구성되어 있으며, 분자량 780kDa의 당단백질 함유하고 있고, 마우스에 투여시 근육과 간에서 글리코겐 농도를 증가시키며, 혈청내 젖산 축적을 감소시키고, 운동력을 증강시키는 매우 뛰어난 효과가 있다.The present invention relates to a method for producing a polymer (Exo-polymer) from Ganoderma lucidum TG (KCTC 10241BP) mycelium culture medium and its use, and to synthesize Ganoderma lucidum TG (KCTC 10241BP) mycelium Inoculate the medium and stir at 50 to 150 rpm while supplying air at a rate of 1vvm at a pH of 4 to 7 and a temperature of 25 to 35 ° C to incubate the liquid for 10 to 30 days, and then centrifuge the culture solution at 5,000 to 15,000 x g for 10 to 30 minutes. After separation, the supernatant was treated with ethanol to obtain a precipitate, lyophilized, dissolved in distilled water, centrifuged and dialyzed, and the separated polymeric material was composed of 17.2% protein and 82.8% carbohydrate, and contained a glycoprotein having a molecular weight of 780kDa. When administered to mice, it has a very good effect of increasing glycogen concentration in muscle and liver, reducing lactate accumulation in serum, and enhancing exercise power. .
Description
본 발명은 영지버섯 균사체의 배양액으로부터 고분자 물질을 생산하는 방법 및 그 용도에 관한 것으로 더욱 상세하게는, 본 발명은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 액체배양물로부터 운동력 증강효과를 가지는 고분자 물질의 생산방법 및 상기 고분자 물질을 마우스에 투여시 근육과 간에서 글리코겐 농도를 증가시키고, 혈청내 젖산축적을 감소시키며, 운동력 증강효과를 가지는 고분자 물질에 관한 것이다.The present invention relates to a method for producing a polymer material from the culture solution of Ganoderma lucidum mycelium, and more particularly, to the use of the present invention, Ganoderma lucidum TG (KCTC 10241BP) mycelium in liquid culture of the mycelium The present invention relates to a method of producing a polymer material and a polymer material having an effect of increasing glycogen concentration in the muscle and liver, reducing serum lactate accumulation, and enhancing exercise power when the polymer material is administered to a mouse.
최근 운동력 및 지구력을 증강시킬 수 있는 자연 물질을 찾기 위하여 많은 연구가 진행되고 있으나 몇편의 연구만이 보고되어 있을 뿐이다. 1972년, Cureton은 밀발효유의 지구력 증강효과와 상기 효과의 활성성분이 옥타코사놀(octacosanol)임을 입증하였으며(Cureton, T. K. 1972. Charles C Thomas, Springfield.), Costill 등은 카페인의 투여가 대사력과 운동행위에 미치는 효과에 대해서 보고하였다(Costill, D. L., G. P. Dalsky, and W. J. Fink. Med. Sci. Sports. 10: 155-158., 1978). 또한 고추의 매운 성분인 캅사이신(Capsaicin)의 운동력 증강 효과에 대하여 많은 연구가 진행되어 왔으며, 김 등은 캅사이신이 수영 지구력 증강에 미치는 영향을 조사하였다(Kawada, T., S. Sakabe, T. Watanabe, M. Yamamoto, and K. Iwai. Proc. Soc. Exp. Biol. Med. 188: 229-33. 1988; Kawada, T., T. Watanabe, T. Takaishi, T. Tanaka, and K. Iwai. Proc. Soc. Exp. Biol. Med. 183: 250-256. 1986; Kim, K. M., T. Kawada, K. Ishihara, K. Inoue, and T. Fushiki. Biosci. Biotech. Biochem. 61: 1718-1723. 1997.).Recently, many studies have been conducted to find natural substances that can enhance athletic and endurance, but only a few studies have been reported. In 1972, Cureton proved that the fermentation effect of wheat fermented milk and its active ingredient is octacosanol (Cureton, TK 1972. Charles C Thomas, Springfield.), Costill et al. The effect on behavior was reported (Costill, DL, GP Dalsky, and WJ Fink. Med. Sci. Sports. 10: 155-158., 1978). In addition, many studies have been conducted on the potentiation effect of capsaicin, a hot ingredient of red pepper, and Kim investigated the effects of capsaicin on the improvement of swimming endurance (Kawada, T., S. Sakabe, T. Watanabe). , M. Yamamoto, and K. Iwai. Proc. Soc.Exp. Biol.Med. 188: 229-33. 1988; Kawada, T., T. Watanabe, T. Takaishi, T. Tanaka, and K. Iwai. ..... Proc Soc Exp Biol Med 183:..... 250-256 1986; Kim, KM, T. Kawada, K. Ishihara, K. Inoue, and T. Fushiki Biosci Biotech Biochem 61: 1718-1723 1997.).
그러나, 지금까지 영지버섯 균사체로부터 분리한 다양한 약리활성 성분이 많 이 연구되고 있으나 영지버섯 균사체에 의해 생산되는 운동력 증강 효과있는 고분자 물질에 대해서는 연구된 바가 없다. However, there are many pharmacologically active ingredients isolated from Ganoderma lucidum mycelium. Although this research is being conducted, there is no research on the polymer material with the enhancing effect produced by Ganoderma lucidum mycelium.
본 발명자는 상기와 같은 점을 착안하여, 운동력 증강 효과를 가지는 신물질을 탐색하던 중 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP)에서 고분자 물질을 추출하고, 상기 고분자 추출물이 마우스에서 수영 지구력 증강효과가 있음을 확인하므로써 본 발명을 완성하였다.The present inventors focus on the above, while searching for a new substance having a potency enhancing effect, extracting a polymer material from Ganoderma lucidum TG (KCTC 10241BP), the polymer extract is effective in enhancing swimming endurance in mice By confirming that the present invention was completed.
따라서, 본 발명의 목적은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 액체 배양물로부터 고분자 물질의 생산방법을 제공함에 있다.Accordingly, an object of the present invention is to provide a method for producing a polymer material from a liquid culture of Ganoderma lucidum TG (KCTC 10241BP) mycelium.
본 발명의 다른 목적은 상기 방법에 의해 생산된 운동력 증강 효과를 가지는 고분자 물질을 제공함에 있다. It is another object of the present invention to provide a polymer material having a motion enhancing effect produced by the method.
본 발명의 상기 목적은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체를 배양하여 고분자 물질을 추출하고, 상기 고분자 추출물질을 마우스에 투여하여 운동력 증강효과를 확인하고, 추출물의 성분을 분석함으로써 달성하였다.The above object of the present invention is achieved by culturing Ganoderma lucidum TG (KCTC 10241BP) mycelium, extracting a polymer material, confirming the effect of enhancing the exercise power by administering the polymer extract to a mouse, and analyzing the components of the extract It was.
본 발명은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 종균을 배양한 다음 균질화하여 접종원을 제조하고 200mL의 영지버섯 합성배지에 접종하여 배양온도 30℃에서 공기공급속도를 1vvm으로 하여 120rpm으로 교반하면서 18일간 액체배양한 후 배양액을 원심분리하여 상층액을 획득하고 에탄올 처리하여 침전물을 획득하여 영지버섯 고분자 추출물을 제조하는 단계; 상기 단계에서 제조한 고분자 추출물을 마우스에 투여하여 수영 지구력 증강효과를 측정하는 단계; 상기 고분자 추출물을 마우스에 투여하여 간 및 근육내의 글리코겐 농도와 혈청내 젖산의 농도에 미치는 영향을 조사하는 단계 및 상기 고분자 추출물의 당과 단백질 함량을 페놀황산법, 로우리법 및 기체크로마토그래피로 분석하는 단계로 구성된다.The present invention is cultured spawn of Ganoderma lucidum TG (KCTC 10241BP) mycelium and then homogenized to prepare the inoculum, inoculated in 200mL Ganoderma lucidum synthetic medium and incubated at 120 ℃ air supply speed to 1rpm at 120rpm 18 days of liquid incubation with stirring to obtain a supernatant by centrifugation of the culture and to obtain a precipitate by ethanol treatment to prepare a Ganoderma lucidum polymer extract; Measuring swimming endurance enhancing effect by administering the polymer extract prepared in the step to the mouse; Administering the polymer extract to a mouse to investigate the effect of glycogen concentration in the liver and muscle and the concentration of lactic acid in serum and analyzing the sugar and protein content of the polymer extract by phenol sulfate, Lawley method and gas chromatography It consists of.
본 발명 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 최적 배양조건은 온도 20∼35℃, pH 4.0∼7.0에서 50∼150rpm으로 교반하면서 10∼30일간 배양하였으며 바람직하게는 온도 25∼30℃, pH 4.0∼5.0 조절하였다.Optimum culture conditions of Ganoderma lucidum TG (KCTC 10241BP) mycelium of the present invention was incubated for 10-30 days with stirring at 50-150 rpm at a temperature of 20-35 ℃, pH 4.0-7.0 and preferably 25-30 ℃ , pH 4.0-5.0 was adjusted.
상기 단계에서 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체 액체배양액은 5,000∼15,000×g로 10∼30분간 원심분리하여 상층액을 획득하였으며 바람직하게는 10,000∼11,000×g로 15∼25분간 원심분리하였다.In this step, Ganoderma lucidum TG (KCTC 10241BP) mycelium liquid culture solution was obtained by centrifugation at 5,000 to 15,000 × g for 10 to 30 minutes, and the supernatant was preferably centrifuged at 10,000 to 11,000 × g for 15 to 25 minutes. Separated.
상기 단계에서 배양액으로부터 획득한 상층액에 상층액 부피의 3∼5배의 에탄올을 처리하여 침전물을 획득하고 침전물을 동결건조한 후 증류수에 용해하여 투석함으로써 고분자 물질을 제조하였다. In the step, the supernatant obtained from the culture solution was treated with ethanol 3 to 5 times the volume of the supernatant to obtain a precipitate. The precipitate was lyophilized and dissolved in distilled water to prepare a polymer material.
동물실험 결과는 평균±표준편차로 나타내었으며 그룹의 평균은 던컨 다중검사 시험에 의해 비교하여 p<0.05수준에서 유의성을 검증하였다.The results of animal experiments were expressed as mean ± standard deviation, and the mean of the group was verified by p <0.05 level compared with Duncan's multiplex test.
본 발명에서 사용한 영지버섯 균사체는 하기의 과정에 의해 분리되어 생명공학연구소에 기탁된 영지버섯(Ganoderma lucidum) TG (KCTC 10241BP)을 사용하였으며 3개월마다 계대배양하였다. Ganoderma lucidum mycelium used in the present invention was separated by the following procedure using Ganoderma lucidum TG (KCTC 10241BP) deposited in the Biotechnology Research Institute and subcultured every three months.
경북 청송군 주왕산에서 채취한 후 무균실에서 자실체의 포자부분을 절개하여 항생제가 포함된 평판(Plate; potato dextrose agar 배지, pH 4.5)에서 포자를 받아 25℃에서 배양하여 순수분리를 하였다. 이어 미강 10 중량%가 포함된 참나무톱밥배지(수분 60 중량%)를 종균병에 넣고 봉한다음 121℃, 60분의 조건으로 멸균하였다. 그 후 무균실에서 실온으로 식힌 후 순수분리한 균을 접종한 다음 30℃에서 배양하였다. 균이 종균병에서 완전히 자란 후 성장 챔버(growth chamber)로 옮겨 뚜껑을 제거하고 습도 90 중량%, 온도 30℃의 조건으로 배양하였다. 버섯의 갓이 생육될 때 습도를 75%로 낮추어 배양하였다. 갓이 생성된 후 65일 간 배양하여 자실체를 얻은 후 포자로 부터 균사체 형성시켜 2002년 5월 3일 생명공학연구소 유전자은행에 기탁하였으며, 2002년 5월 10일로 기탁번호 KCTC 10241BP를 받았다. After harvesting from Juwangsan, Cheongsong-gun, Gyeongbuk, the spores of fruiting bodies were cut in a clean room and spores were collected on a plate containing antibiotics (Plate; potato dextrose agar medium, pH 4.5). Subsequently, oak sawdust medium (water content of 60% by weight) containing 10% by weight of rice bran was placed in a seed bottle and sealed, followed by sterilization at 121 ° C. for 60 minutes. Then, after cooling to room temperature in a sterile chamber was inoculated with purely isolated bacteria and incubated at 30 ℃. After the bacteria were completely grown in the spawn bottle, they were transferred to a growth chamber, and the caps were removed, and cultured under conditions of a humidity of 90% by weight and a temperature of 30 ° C. When the fungi of the mushrooms were grown, the humidity was reduced to 75% and incubated. After the spat was produced, it was cultured for 65 days to obtain an fruiting body, and formed mycelium from the spores and deposited it on the May 3, 2002, the Biotechnology Research Institute Gene Bank, and received the accession number KCTC 10241BP as of May 10, 2002.
본 발명에서 사용한 실험동물은 5주령의 마우스로서(Japan SLC, Hamamatsu, 일본)를 사용하였다. 동물실험실의 온도는 22±0.5℃, 습도 50±5%로 유지하였으며 12시간 간격으로 명암조절하였다. 실험기간동안 수분은 자유공급하였으며, 일반 식이요법시켰다. The experimental animal used in the present invention was used as a 5 week old mouse (Japan SLC, Hamamatsu, Japan). The temperature of the animal laboratory was maintained at 22 ± 0.5 ℃, humidity 50 ± 5% and the contrast was adjusted at 12 hour intervals. Moisture was freely supplied during the experiment, followed by general diet.
상기 단계에서 글리코겐 농도는 Fushiki, T등의 방법(Fushiki, T., K. et al., J. Nutr. 125: 531-539)을 사용하여 측정하였으며, 혈청내 L-젖산의 농도는 Kyowa Medes commercial kit(Determiner LA, 도교, 일본)를 사용하여 효소적 분석방법에 의해 측정하였다.Glycogen concentration in this step was measured using a method such as Fushiki, T (Fushiki, T., K. et al., J. Nutr. 125: 531-539), and the concentration of L-lactic acid in serum was Kyowa Medes. It was measured by enzymatic analysis using a commercial kit (Determiner LA, Taoism, Japan).
이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만,본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다. Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.
실시예 1: 영지버섯( Example 1: Ganoderma lucidum mushroom Ganoderma lucidum Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 배양 및 고분자 물질의 추출 ) Culture of TG (KCTC 10241BP) Mycelia and Extraction of High Polymers
고분자 물질을 생산하기 위하여 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체를 200ml의 영지버섯 합성배지(galactose 0.1%, sucrose 0.9%, xylose 0.1%, glucose 0.9%, yeast extract 0.05%, peptone 0.2%, potato dextrose broth 0.2%, NH 4 H 2 PO 4 0.05%, DL-serine 0.05%, KH 2 PO 4 0.1%, CaCl 2 0.06%, MgSO 4 ·7H 2 O 0.2%, FeSO 4 ·7H 2 O 0.002%, ZnSO 4 ·7H 2 O 0.002%, MnSO 4 ·H 2 O 0.002%, tiamine-HCl 0.0001%)에 접종하고 30℃에서 120rpm으로 교반하면서 18일간 배양하였다. 상기 배양한 균사체 배양액은 도 1에 도시한 공정 단계별로 추출하였는데, 우선 10,447×g에서 20분간 원심분리한 다음 상층액을 수득하고 상층액 부피의 4배의 에탄올을 처리하여 침전물을 획득한 후 동결건조하였다. 상기 동결건조된 분말을 10mg/mL의 농도가 되게 증류수에 용해하고 10,447×g에서 20분간 원심분리하여 상층액을 획득한 다음 투석하고 동결건조하여 고분자 물질(exo-polymer)를 분리하였다. Ganoderma lucidum TG (KCTC 10241BP) mycelium was mixed with 200ml of Ganoderma lucidum TG (KCTC 10241BP) mycelium (galactose 0.1%, sucrose 0.9%, xylose 0.1%, glucose 0.9%, yeast extract 0.05%, peptone 0.2%). , potato dextrose broth 0.2%, NH 4 H 2 PO 4 0.05%, DL-serine 0.05%, KH 2 PO 4 0.1%, CaCl 2 0.06%, MgSO 4 · 7H 2 O 0.2%, FeSO 4 · 7H 2 O 0.002 %, ZnSO 4 · 7H 2 O 0.002%, MnSO 4 · H 2 O 0.002%, tiamine-HCl 0.0001%) and incubated for 18 days while stirring at 120rpm at 30 ℃. The cultured mycelium culture solution was extracted by the process step shown in Figure 1, first centrifuged at 10,447 × g for 20 minutes, then obtained a supernatant and treated with ethanol four times the volume of the supernatant to obtain a precipitate after freezing Dried. The lyophilized powder was dissolved in distilled water to a concentration of 10 mg / mL and centrifuged at 10,447 × g for 20 minutes to obtain a supernatant, followed by dialysis and lyophilization to separate a polymer (exo-polymer).
실험예 1: 본 발명 고분자 물질(exo-polymer)을 마우스에 투여시켰을 경우 마우스의 사료 섭취량과 체중변화의 운동 지구력 효과 조사 Experimental Example 1: Investigation of the exercise endurance effect of the feed intake and body weight of the mouse when the exo-polymer of the present invention is administered to the mouse
상기 실시예1의 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체로부터 추출한 고분자 물질을 마우스에 경구투여 하였고, 경구투여에 따른 마우스의 사 료 섭취량과 체중변화에 미치는 영향을 조사하였다. 3주동안의 사료 섭취량과 체중변화를 표 1에 나타내었다. 고분자 물질(exo-polymer)의 투여는 체중과 사료 섭취량에 유의적인 영향을 미치지 않았다. 더욱이 고분자 물질(exo-polymer)을 경구투여한 마우스는 전반적인 행동양식에 변화가 없었으며, 치사된 동물도 없었다. 상기와 같은 결과로부터 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체 유래의 고분자 물질의 경구투여는 무해함을 알 수 있었다.The polymeric material extracted from Ganoderma lucidum TG (KCTC 10241BP) mycelium of Example 1 was orally administered to mice, and the effects of oral administration on feed intake and body weight of mice were investigated. Table 3 shows the changes in feed intake and body weight over the three weeks. The administration of exo-polymer had no significant effect on body weight and feed intake. Furthermore, mice given oral administration of exo-polymer had no change in overall behavior and no animals were killed. From the above results, it was found that oral administration of Ganoderma lucidum TG (KCTC 10241BP) mycelium-derived polymer material is harmless.
실험예 2 : 영지버섯( Experimental Example 2: Ganoderma lucidum mushroom Ganoderma lucidum Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 고분자 추출물을 투여한 마우스의 수영지구력 능력 측정 ) Measurement of swimming endurance ability of mice treated with polymer extract of TG (KCTC 10241BP) mycelium
수영능력효과를 측정하기 위해 Matsymoto(Matsymoto et al., J.Appl. Physiol., Physiol. 81:1843-1849)의 방법에 따라 실시하였다. 1주일의 예비실험기간 갖은 후 실험동물은 30분 동안 81iter/min의 유속으로 수영할 수 있었다. 상기 마우스를 대조구(12마리)와 GL투여구(12마리)의 2그룹으로 나누어 실시하였는데, GL투여구는 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체로부터 추출한 고분자물질은 체중 1kg 당 100mg이 되게 stomach tube를 사용하여 매일 경구투여하였고, 대조구는 염분을 섭취시켰다.Matsymoto (Matsymoto et al., J. Appl. Physiol., Physiol. 81: 1843-1849) was used to measure the effect of swimming ability. After a week of preliminary testing, the animals were able to swim at a rate of 81 iter / min for 30 minutes. The mice were divided into two groups, a control group (12 animals) and a GL administration group (12 animals), and the GL administration group was 100 mg / kg body weight of the polymer extracted from the Ganoderma lucidum TG (KCTC 10241BP) mycelium. Daily oral administration was performed using the stomach tube, and the control group consumed saline.
상기 경구투여한 마우스의 수영지구력테스트(swimming endurance test)를 실시하였다. 1 라운드를 수영을 마친 후 마우스는 48시간의 회복시간을 가졌다. 상기와 같은 사이클을 3주 동안 계속하였고, 매 사이클마다 마우스의 최대 수영시간을 측정하였으며, 상기 실험동물이 7초안에 숨을 쉬기 위하여 물 표면으로 나오는 것에 실패할 경우 피곤한 것으로 판단하여 그 시간을 측정하였다(Matsymoto et al., J.Appl. Physiol., Physiol. 81:1843-1849). 생물학적 주기에 따른 신체활성(physical activity)으로 인한 편차를 피하기 위하여 각 사이클의 실험은 10:00∼18:00시에 실시하였다. A swimming endurance test of the orally administered mice was conducted. After swimming one round, the mice had a 48 hour recovery time. The cycle was continued for 3 weeks, and the maximum swimming time of the mouse was measured every cycle, and when the experimental animal failed to come out of the water surface to breathe within 7 seconds, it was judged to be tired and measured. (Matsymoto et al., J. Appl. Physiol., Physiol. 81: 1843-1849). In order to avoid deviation due to physical activity according to the biological cycle, each cycle experiment was conducted at 10: 00-18: 00.
실험결과를 도 2에 나타내었다. GL 투여구와 대조구 마우스의 수영능력에 있어서 본 발명 고분자 물질의 효과가 10일까지는 우월하게 나타나지 않았지만 12일이 경과 후부터는 GL 투여구의 수영능력이 유의적인 향상됨을 알 수 있었고 대조구에 비해 10분 이상 더 길게 수영하였다. The experimental results are shown in FIG. 2. The effect of the polymers of the present invention on the swimming ability of the GL and control mice did not appear to be superior until 10 days, but after 12 days, the swimming ability of the GL treatment was significantly improved and was longer than 10 minutes compared to the control. I swam.
실험예 3 : 간, 근육내 글리코겐 농도 및 혈청내 젖산농도측정 Experimental Example 3 Measurement of Glycogen Concentration and Serum Lactic Acid Concentration in Liver and Muscle
지구력이 증강되는 이유를 결정하기 위하여 대조구와 GL 투여구의 수영하기 전과 수영한 후 마우스 근육의 글리코겐, 간의 글리코겐과 혈청내 젖산의 함량을 조사하였다. To determine the reason why the endurance is enhanced, the glycogen, liver glycogen and serum lactate content of the mouse muscles were examined before and after swimming in the control and GL treatments.
실험예2의 3주 실험기간이 끝낸 다음 48h 후에 대조구와 GL 투여구의 마우스중 절반의 마우스(각각 6마리)에 다시 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체로부터 추출한 고분자 물질(100mg/kg 체중)과 염분을 각각 투여하고, 2시간의 rest time을 준 후 20분간 수영시켰다. 근육과 간의 글라이코겐 수치와 과 혈청내 젖산의 수치는 수영 20분후에 바로 측정하였으며, 그 값은 3주 실험한 마우스의 나머지반을 대조구로 하여 비교하였다.48 h after the end of the three-week experimental period in Experiment 2, a high-molecular substance extracted from Ganoderma lucidum TG (KCTC 10241BP) mycelium (100 mg / kg) in half of the mice in the control and GL administration mice (6 mice each). Body weight) and salinity, respectively, followed by a 2 hour rest time and swimming for 20 minutes. Muscle and liver glycogen levels and serum levels of lactic acid were measured immediately after 20 minutes of swimming, and the values were compared with the other half of mice treated for 3 weeks.
실험결과 도 3에 나타난 바와 같이, 3주의 실험 후(stabilized group), 대조구는 GL 투여구와 비교하여 근육내 글리코겐과 간의 글리코겐 수치는 낮게 나타났고 혈청내 젖산수치가 유의적인 수준은 아니였으나 상대적으로 높게 나타났다. 수영 테스트 20분 후 대조구와 GL 투여구에서 근육과 간의 글리코겐 수치는 유의적으로 떨어지는 것이 관찰되었으나, 대조구에 비해 GL 투여구의 글리코겐 수치가 더 높게 나타났다. 대조구는 근육내 글리코겐이 34.42%인 반면, GL 투여구는 43.11%이었고, 간의 글리코겐 수치가 대조구에서 85.29%와 GL투여구에서 95.30%의 글리코겐 수치를 나타내었다. 수영 테스트 20분 후 마우스의 대조구에서 18.61%로 젖산축적이 증가함을 알 수 있었다. 대조적으로 GL 투여구의 젖산 축적은 유의적으로 변하지 않았다. As shown in FIG. 3, after 3 weeks of stabilized group, the control group showed lower levels of intramuscular glycogen and hepatic glycogen compared to the GL-treated group, and the serum lactate level was not high, but was relatively high. appear. Twenty minutes after the swimming test, the glycogen levels in muscle and liver were significantly decreased in the control and GL treatments, but the glycogen levels in the GL treatments were higher than the control. The control group had an intramuscular glycogen of 34.42%, whereas the GL group had 43.11%, and the liver glycogen levels were 85.29% in the control group and 95.30% in the GL group. Twenty minutes after the swimming test, lactate accumulation increased to 18.61% in the control of mice. In contrast, lactate accumulation in the GL administration did not change significantly.
결론적으로, 본 발명의 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체 유래의 고분자 물질은 지구력 증강효과를 가지며, 고분자 물질은 첫 10일 동안은 수영하는 시간에 아무 영향을 미치지 못하였으나 12일 후부터는 수영능력 증강능력을 보이므로 고분자 물질 투여에 따른 반응효과를 위해서는 일정한 시간('period of habituation')이 필요한 것으로 나타났다. 또한 3주의 수영지구력테스트 후 48시간에 측정한 실험구(stabilized group)의 간과 근육내 글리코겐 수치는 증가하지 않았으나, 다시 20분 더 수영시킨 실험구(post-swimming experimental group)의 고분자 물질을 투여한 마우스가 대조구에 비해 간과 근육내 높은 글리코겐 수치와 혈청내 낮은 젖산의 축적을 가져와 지구력이 증강됨을 알 수 있었다.In conclusion, Ganoderma lucidum TG (KCTC 10241BP) mycelium-derived polymer material of the present invention has an endurance enhancing effect, and the polymer material had no effect on swimming time for the first 10 days, but after 12 days Because of the ability to enhance swimming ability, a certain amount of time ('period of habituation') was required for the reaction effect of the administration of the polymer substance. In addition, glycogen levels in the liver and muscle groups of the stabilized group, which were measured 48 hours after the swimming endurance test of 3 weeks, did not increase, but were again administered with the polymer of the post-swimming experimental group, which had been swimming for another 20 minutes. Mice showed higher endurance due to higher glycogen levels in the liver and lower accumulation of serum lactate in the liver and muscle than the control.
실험예 4: 본 발명 고분자 물질의 당과 단백질 함량을 분석 Experimental Example 4 Analysis of Sugar and Protein Contents of the Polymeric Material of the Present Invention
상기 실시예 3에서 제조한 본 발명 균체외 고분자 물질의 당과 단백질 함량을 분석하였다. 총 단백질은 로우리[Lowry, O. H., Rosebrough, N. J., Farr, L., and Rindall, R. J., J. Biol. Chem ., 193, 256(1951)]법으로 분석하였으며 표준물질로는 소 혈청 알부민을 사용하였다. 총 탄수화물 함량은 표준물질로 포도당과 갈락토오즈(1:1, w/w)를 사용하여 페놀황산방법에 의해 분석하였으며, 아미노산과 탄수화물의 조성은 가수분해(hydrolysis)와 아세틸화(acetylation)방법(Song, C. H., B. K. Yang, K. S. Ra, D. H. Shon, E. J. Park, G. I. Go, and Y. H. Kim. J. Microbiol. Biotechnol. 8: 277-279. 1998)에 기초를 둔 HPLC와 기체 크로마토그래 피에 의해 측정하였다.The sugar and protein content of the extracellular polymer material of the present invention prepared in Example 3 was analyzed. Total protein is Lowry, OH, Rosebrough, NJ, Farr, L., and Rindall, RJ, J. Biol. Chem ., 193, 256 (1951)] and bovine serum albumin was used as a standard. Total carbohydrate content was analyzed by phenol sulfate method using glucose and galactose (1: 1, w / w) as a standard, and the composition of amino acids and carbohydrates was determined by hydrolysis and acetylation methods. By HPLC and gas chromatography based on (Song, CH, BK Yang, KS Ra, DH Shon, EJ Park, GI Go, and YH Kim. J. Microbiol. Biotechnol. 8: 277-279. 1998). Measured.
영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 배양액으로부터 획득된 고분자 물질(exo-polymer)을 0.2M 의 NaCl에 용해하고, 0.2M NaCl로 equilibrate되고, 5ml/tube volume의 유속(flow rate)으로 세파로스 CL-6B 컬럼(2.6×99㎝)에서 gel-filtration한 결과, 분자량 780kDa의 분획을 얻었다.The exo-polymer obtained from the culture of Ganoderma lucidum TG (KCTC 10241BP) mycelium is dissolved in 0.2 M NaCl, equilibrated with 0.2 M NaCl, and flow rate of 5 ml / tube volume. The gel-filtration by Sepharose CL-6B column (2.6 * 99cm) gave the fraction of molecular weight 780kDa.
화학분석적으로 본 발명 고분자 물질은 82.8%의 탄수화물과 17.2% 단백질을 포함하고 있었으며, 산성의 당은 검출되지 않았다. 6개의 당이 카보하이드레이트 모이에티(carbohydrate moiety)를 구성하였으며, 히스티딘, 세린, 알라닌, 발린이 단백질의 주요 아미노산으로 확인되었고, 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 고분자물질(exo-polymer)은 당단백질임을 알 수 있었다.In chemical analysis, the polymer material of the present invention contained 82.8% carbohydrate and 17.2% protein, and no acidic sugar was detected. Six sugars constituted the carbohydrate moiety, and histidine, serine, alanine and valine were identified as major amino acids of the protein, Ganoderma lucidum TG (KCTC 10241BP) mycelium. -polymer) was found to be a glycoprotein.
이상, 상기 실시예를 통하여 설명한 바와 같이 본 발명은 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체 배양액으로부터 고분자 물질 및 그 추출방법을 제공하는 효과가 있으며, 상기 고분자 물질은 운동력 증강효과가 있으므로 생물의약산업상 및 기능성식품산업상 매우 유용한 발명인 것이다.As described above, the present invention has the effect of providing a polymer material and its extraction method from Ganoderma lucidum TG (KCTC 10241BP) mycelium culture medium, and the polymer material has a potency enhancing effect It is a very useful invention in the pharmaceutical industry and functional food industry.
도 1은 본 발명 영지버섯( Ganoderma lucidum ) TG (KCTC 10241BP) 균사체의 액체 배양액으로부터 고분자 물질을 획득하는 방법을 도시한 개략도이다.1 is a schematic diagram illustrating a method of obtaining a polymer material from a liquid culture solution of Ganoderma lucidum TG (KCTC 10241BP) mycelium of the present invention.
도 2는 지구력 측정 시간은 마우스가 물속에 가라앉아 더 이상 수면위로 올라오지 못하는 시간을 측정한 결과를 나타낸 그래프이다. Figure 2 is a graph showing the endurance measurement time is a result of measuring the time that the mouse submerged in the water no longer rise above the water surface.
도 3은 3주간 수영시킨 후 48시간 안정시킨 실험구와 그 후 20분 수영한 실험구의 근육내 글리코겐, 간의 글리코겐, 혈청내 젖산의 농도의 변화를 측정한 그래프이다. 3 is a graph measuring changes in the concentrations of intramuscular glycogen, liver glycogen, and serum lactate in the experimental group stabilized for 48 hours after swimming for 3 weeks and the experimental group for 20 minutes.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0034215A KR100470734B1 (en) | 2002-06-19 | 2002-06-19 | Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0034215A KR100470734B1 (en) | 2002-06-19 | 2002-06-19 | Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030097062A KR20030097062A (en) | 2003-12-31 |
KR100470734B1 true KR100470734B1 (en) | 2005-02-21 |
Family
ID=32387633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0034215A KR100470734B1 (en) | 2002-06-19 | 2002-06-19 | Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100470734B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006119774A1 (en) * | 2005-05-13 | 2006-11-16 | Medimush As | Feed or food products comprising fungal material |
US7514085B2 (en) | 2004-07-16 | 2009-04-07 | Medimush A/S | Immune modulating compounds from fungi |
US9072776B2 (en) | 2005-06-15 | 2015-07-07 | Glycanova As | Anti-cancer combination treatment and kit-of-parts |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO20014256D0 (en) | 2001-09-03 | 2001-09-03 | Bjoern Kristiansen | Preparation of immunostimulatory compound |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01121302A (en) * | 1987-11-05 | 1989-05-15 | Higashimaru Shoyu Kk | Mucilaginous polysaccharide substance and production thereof |
KR960000075A (en) * | 1994-06-28 | 1996-01-25 | 한경우 | Artificial liquid culture of Ganoderma lucidum (Bulocho) mycelium and extraction and purification method of immunoactive substance |
KR960031619A (en) * | 1995-02-20 | 1996-09-17 | 이신영 | Production method of polysaccharides by liquid culture of Ganoderma lucidum |
KR20010110367A (en) * | 2001-08-31 | 2001-12-13 | 송치현 | A process for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum and the use of the same |
-
2002
- 2002-06-19 KR KR10-2002-0034215A patent/KR100470734B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01121302A (en) * | 1987-11-05 | 1989-05-15 | Higashimaru Shoyu Kk | Mucilaginous polysaccharide substance and production thereof |
KR960000075A (en) * | 1994-06-28 | 1996-01-25 | 한경우 | Artificial liquid culture of Ganoderma lucidum (Bulocho) mycelium and extraction and purification method of immunoactive substance |
KR960031619A (en) * | 1995-02-20 | 1996-09-17 | 이신영 | Production method of polysaccharides by liquid culture of Ganoderma lucidum |
KR20010110367A (en) * | 2001-08-31 | 2001-12-13 | 송치현 | A process for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum and the use of the same |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7514085B2 (en) | 2004-07-16 | 2009-04-07 | Medimush A/S | Immune modulating compounds from fungi |
US7682615B2 (en) | 2004-07-16 | 2010-03-23 | Beka Holding As | Immune modulating compounds from fungi |
WO2006119774A1 (en) * | 2005-05-13 | 2006-11-16 | Medimush As | Feed or food products comprising fungal material |
US9072776B2 (en) | 2005-06-15 | 2015-07-07 | Glycanova As | Anti-cancer combination treatment and kit-of-parts |
Also Published As
Publication number | Publication date |
---|---|
KR20030097062A (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6383799B1 (en) | Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | |
CN1507772A (en) | Method for preparing hickory chick by liquid deep fermentation and product thereof | |
CN109694833B (en) | Lactobacillus plantarum and application thereof in reducing uric acid, improving allergy and reducing blood sugar | |
CN109694834B (en) | Lactobacillus plantarum and application thereof in eliminating body fat, reducing hepatomegaly and resisting inflammation | |
CN1932027A (en) | Double enzyme hydrolysis process for preparing soybean peptide without bitter | |
JP3364579B2 (en) | Antihypertensive agent and method for producing the same | |
CN1698879A (en) | Product having sobering up and liver protecting functions and its preparation method and usage | |
KR20070005950A (en) | Method for preparing of mushroom culture material fortified gamma-aminobutyric acid | |
CN1916028A (en) | Polysaccharide outside cyst of lactobacillus casei and crude product, prepartion method and application | |
CN109694832B (en) | Lactobacillus plantarum and application thereof in reducing blood fat, liver function index, uric acid and resisting inflammation | |
JP4313615B2 (en) | Novel lactic acid bacteria having immunostimulatory activity and γ-aminobutyric acid producing ability, and use thereof. | |
KR100470734B1 (en) | Method for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum TG(KCTC 10241BP) and the use thereof | |
CN117946939A (en) | Lactobacillus plantarum SM2 and application thereof in preparation of cholesterol-lowering and sleep-aiding foods and medicines | |
JP4426506B2 (en) | New lactic acid bacteria and beverages using new lactic acid bacteria | |
CN117946940A (en) | Lactobacillus plantarum SM1 and application thereof in preparing food and medicine for regulating intestines and stomach and losing weight | |
JP3902015B2 (en) | Manufacturing method of health nutrition food | |
KR100347267B1 (en) | Functional beverage containing submerged culture broth of Paecilomyces sp. and process for preparation thereof | |
CN117044935A (en) | Nutritional composition formula with uric acid reducing function and preparation method thereof | |
CN1244686C (en) | Lactobacillus casei LC2W strain and its application in treatment of high blood pressure | |
KR20050014237A (en) | Functional Soju containing submerged culture broth of mushrooms and process for preparation thereof | |
JPS6326088B2 (en) | ||
KR20010110367A (en) | A process for preparation of exo-polymers from submerged mycelial culture of Ganoderma lucidum and the use of the same | |
CN1245720A (en) | Medicinal composition containing calcineurin B subunit | |
CN109722462B (en) | Jellyfish blood fat reducing peptide and preparation method thereof | |
CN106011205A (en) | Fermented type polypeptide biological base material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130125 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140127 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |